JACQUES GONELLA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JACQUES GONELLA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JACQUES GONELLA. JACQUES GONELLA is Director in ANTARES PHARMA, INC. ($ATRS).
Latest Insider Trading Transactions of JACQUES GONELLA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2019 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 3.65 | 200,000 | 730,000 | 9,385,848 | 9.6 M to 9.4 M (-2.09 %) |
Oct 04 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 3.79 | 400,000 | 1,516,000 | 9,585,848 | 10 M to 9.6 M (-4.01 %) |
Aug 15 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 3.09 | 49,507 | 152,977 | 9,985,848 | 10 M to 10 M (-0.49 %) |
Aug 10 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 3.09 | 250,493 | 774,023 | 10,035,355 | 10.3 M to 10 M (-2.44 %) |
Jun 20 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.95 | 565 | 1,667 | 10,285,848 | 10.3 M to 10.3 M (-0.01 %) |
Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.77 | 100,000 | 277,000 | 10,286,413 | 10.4 M to 10.3 M (-0.96 %) |
Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.69 | 100,000 | 269,000 | 10,386,413 | 10.5 M to 10.4 M (-0.95 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 20,259 | 54,699 | 10,486,413 | 10.5 M to 10.5 M (-0.19 %) |
Jun 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 23,129 | 62,448 | 10,506,672 | 10.5 M to 10.5 M (-0.22 %) |
Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 10,529,801 | 10.6 M to 10.5 M (-0.94 %) |
Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.65 | 100,000 | 265,000 | 10,629,801 | 10.7 M to 10.6 M (-0.93 %) |
Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.70 | 56,612 | 152,852 | 10,729,801 | 10.8 M to 10.7 M (-0.52 %) |
Jun 01 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.60 | 78,938 | 205,239 | 10,786,413 | 10.9 M to 10.8 M (-0.73 %) |
Jun 01 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 10,865,351 | 11 M to 10.9 M (-0.91 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 10,965,351 | 11.1 M to 11 M (-0.90 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.53 | 94,682 | 239,545 | 11,065,351 | 11.2 M to 11.1 M (-0.85 %) |
May 24 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.53 | 5,318 | 13,455 | 11,160,033 | 11.2 M to 11.2 M (-0.05 %) |
May 22 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.60 | 21,062 | 54,761 | 11,165,351 | 11.2 M to 11.2 M (-0.19 %) |
May 18 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.55 | 100,000 | 255,000 | 11,186,413 | 11.3 M to 11.2 M (-0.89 %) |
May 18 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.52 | 100,000 | 252,000 | 11,286,413 | 11.4 M to 11.3 M (-0.88 %) |
May 16 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 11,386,413 | 11.5 M to 11.4 M (-0.87 %) |
May 16 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.50 | 100,000 | 250,000 | 11,486,413 | 11.6 M to 11.5 M (-0.86 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.47 | 100,000 | 247,000 | 11,586,413 | 11.7 M to 11.6 M (-0.86 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.36 | 100,000 | 236,000 | 11,686,413 | 11.8 M to 11.7 M (-0.85 %) |
May 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.47 | 150,000 | 371,190 | 11,786,413 | 11.9 M to 11.8 M (-1.26 %) |
May 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.46 | 150,000 | 369,210 | 11,936,413 | 12.1 M to 11.9 M (-1.24 %) |
May 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 0.85 | 30,000 | 25,500 | 0 | |
May 07 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 0.85 | 30,000 | 25,500 | 12,086,413 | 12.1 M to 12.1 M (+0.25 %) |
Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.65 | 30,000 | 49,500 | 0 | |
Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.65 | 30,000 | 49,500 | 12,056,413 | 12 M to 12.1 M (+0.25 %) |
Jan 12 2017 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | J | 0.00 | 2,900,000 | 0 | 12,026,413 | 9.1 M to 12 M (+31.78 %) |
Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.12 | 150,000 | 168,000 | 150,000 | |
Mar 21 2016 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 0.72 | 100,000 | 72,000 | 9,126,413 | 9 M to 9.1 M (+1.11 %) |
Dec 18 2015 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.54 | 20,000 | 30,800 | 0 | |
Dec 18 2015 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.54 | 20,000 | 30,800 | 9,026,413 | 9 M to 9 M (+0.22 %) |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 2.18 | 99,395 | 216,681 | 99,395 | |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 4,283,476 | |
Apr 01 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 1.06 | 33,700 | 35,722 | 13,648,760 | 13.6 M to 13.6 M (+0.25 %) |
Mar 31 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 0.98 | 65,000 | 63,700 | 13,615,060 | 13.6 M to 13.6 M (+0.48 %) |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 4,254,916 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 13,515,997 | |
Aug 31 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.23 | 80,000 | 98,400 | 13,515,497 | 13.4 M to 13.5 M (+0.60 %) |
Aug 30 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.18 | 11,000 | 12,980 | 12,935,497 | 12.9 M to 12.9 M (+0.09 %) |
Aug 27 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.00 | 125,000 | 125,000 | 12,924,497 | 12.8 M to 12.9 M (+0.98 %) |
Aug 26 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.01 | 100,000 | 101,000 | 12,799,497 | 12.7 M to 12.8 M (+0.79 %) |
Aug 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.06 | 125,000 | 132,500 | 10,299,497 | 10.2 M to 10.3 M (+1.23 %) |
Aug 24 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.07 | 100,000 | 107,000 | 12,587,497 | 12.5 M to 12.6 M (+0.80 %) |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 25,000 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 25,000 | |
May 28 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 0.96 | 100,000 | 96,000 | 12,942,497 | 12.8 M to 12.9 M (+0.78 %) |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.95 | 500 | 475 | 25,000 | |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.01 | 2,000 | 2,020 | 25,000 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.32 | 500 | 660 | 25,000 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 57,000 | |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 55,000 |
Page: 1